CIHR and NSERC terminate Collaborative Health Research Projects program, BC’s government invests in life sciences to boost health research, Ontario Genomics and CANSSI Ontario award inaugural postdoctoral fellowships in genome data science, Lululemon founder gives $100 million for muscle disorder research, a strategy to make Manitoba a leader in sustainable protein production, and more.
Organization: Lunenfeld-Tanenbaum Research Institute
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
CIHR and partners invest $24.5M to study cannabis
The Canadian Institutes of Health Research and partners are investing $24.5 million to explore the health risks and benefits of cannabis.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...